CM&R Track the topics, authors and articles important to you
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Medicine & Research
Volume 2, Number 2 : 89 -97
doi:
© 2004 Marshfield Clinic
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bayer-Garner, I. B.
Right arrow Articles by Tschen, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bayer-Garner, I. B.
Right arrow Articles by Tschen, J. A.


Original Research

The Immunopathology of Regression in Benign Lichenoid Keratosis, Keratoacanthoma and Halo Nevus

Ilene B. Bayer-Garner, MD

Department of Pathology, Marshfield Clinic, Marshfield, Wisconsin

Doina Ivan, MD

University of Texas, Houston, Texas

Mary R. Schwartz, MD

Baylor College of Medicine, Houston, Texas

Jaime A. Tschen, MD

St. Joseph Dermatopathology, Houston, Texas

REPRINT REQUESTS: Ilene B. Bayer-Garner, MD, Department of Pathology, Marshfield Clinic, 1000 North Oak Avenue, Marshfield, WI 54449, Telephone: 715-387-7654, Fax: 715-389-3808, Email: bayer-garner.ilene{at}marshfieldclinic.org

BACKGROUND

Regression is a phenomenon present in a variety of cutaneous lesions. It is likely that similar immunologic mechanisms explain the phenomenon of spontaneous regression occurring in the various lesions.

METHODS

Twenty-seven specimens, nine each of halo nevus, keratoacanthoma, and benign lichenoid keratosis, including three examples each of predominantly early, mid, and late regression were examined with antibodies to HLA-II, CD1a, CD3, CD4, CD8, CD20, CD34, CD56, and CD68.

RESULTS

Epidermotropism of inflammatory cells, including CD1a positive, CD68 positive, CD3 positive, and CD8 positive cells, was present in benign lichenoid keratosis and keratoacanthoma, but not in halo nevus. In halo nevus, the nests of halo nevus cells tended to be infiltrated by CD1a positive, CD68 positive, CD3 positive, and CD8 positive cells. The blood vessels exhibited endothelial cell swelling with luminal narrowing and disruption within the dermis of all lesions. The CD1a positive cells were increased in number in lesional epidermis except in keratoacanthoma lesions where the density of CD1a positive cells was increased in the epithelial lip, but decreased within the epithelial portion of the keratoacanthoma proper. Conversely, the CD8 positive cells were scarce in the dermis below the epithelial lip of the keratoacanthoma, but increased in the dermis of the neoplastic epithelium. CD1a positive cells were also seen throughout the dermal portion of the lesion, particularly at the lesion base. In halo nevus, the CD1a positive cells and CD68 positive cells within the lesions were larger than those in non-lesional skin, indicating activation. The composition of the inflammatory infiltrate varied within each lesion type according to stage of regression, but T-lymphocytes predominated.

CONCLUSION

Cytotoxic T-cells may be the final common denominator of regression in benign lichenoid keratosis, keratoacanthoma, and halo nevus. In halo nevus, cytotoxic T-cells may play the predominant role in regression. In keratoacanthoma and benign lichenoid keratosis, cytotoxic T-cells play a pivotal role, but additional mechanisms may also be involved in the phenomenon of regression. Benign lichenoid keratoses progress through stages of regression accompanied by varying proportions of inflammatory cells, including CD3, CD4, and CD8 positive T-lymphocytes, natural killer cells, macrophages and Langerhans cells.


Key Words: Nevus, halo • Keratosis, diagnosis/pathology • Lichenoid eruptions/pathology • Skin neoplasms/pathology • Keratoacanthoma




This article has been cited by other articles:


Home page
Arch DermatolHome page
N. Somani, M. Martinka, R. I. Crawford, J. P. Dutz, and J. K. Rivers
Treatment of Atypical Nevi With Imiquimod 5% Cream
Arch Dermatol, March 1, 2007; 143(3): 379 - 385.
[Abstract] [Full Text] [PDF]


Home page
Arch DermatolHome page
E. Arai, M. Shimizu, T. Tsuchida, S. Izaki, F. Ogawa, and T. Hirose
Lymphomatoid Keratosis: An Epidermotropic Type of Cutaneous Lymphoid Hyperplasia: Clinicopathological, Immunohistochemical, and Molecular Biological Study of 6 Cases
Arch Dermatol, January 1, 2007; 143(1): 53 - 59.
[Abstract] [Full Text] [PDF]


Home page
Clin Med ResHome page
D. M. Elston
Mechanisms of Regression
Clin. Med. Res., May 1, 2004; 2(2): 85 - 88.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by Marshfield Clinic.